
Business
AstraZeneca shares slide 9% after heart treatment disappoints in trial
UK pharmaceutical company said Wainua drug did not meet goal of reducing cardiovascular deaths

UK pharmaceutical company said Wainua drug did not meet goal of reducing cardiovascular deaths